The “Break Up Big Medicine Act”: Potential Impacts for Healthcare Investors

A newly-introduced Senate bill called the “Break Up Big Medicine Act” proposes a federal prohibition on both new and existing common ownership or control of insurers, pharmacy benefit managers (“PBMs”), drug or medical device wholesalers, and certain medical service provider entities. The bipartisan proposal, introduced by Senators Warren and Hawley, is intended as a cost-reduction and patient-protection measure that carries potentially significant implications for investors in diversified... By: Proskauer - Health Care Law Brief